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Mohammad Jafar Ghaempanah, MD; Kaveh Abri Aghdam, MD; Zahra Mirbolouk Jalali, MSAbstractPurpose: To assess the effect of homatropine eye drops on pain after photorefractive keratectomy (PRK).
Methods: This randomized, double masked, interventional study included 15 patients (30 eyes) who underwent bilateral PRK.
After operation, patients received homatropine eye drops, 4 times daily in only one eye (homatropine eye). The level of pain
was evaluated using visual analogue scale (VAS), verbal rating scale (VRS) and pain rating index (PRI) at 0.5, 24 and 48 h after
operation.
Results: The level of pain was statistically similar between the two eyes half an hour after operation, however, homatropine eyes
had significantly less pain 24 h after operation compared to fellow eyes (2.5 ± 1.9 vs 5.3 ± 2.5, P = 0.004 for VAS, 2.0 ± 1.2 vs
3.2 ± 0.9, P = 0.023 for VRS, and 9.4 ± 5.7 vs 16.0 ± 9.0, P = 0.031 for PRI). Also, 48 h after surgery, the pain scales were less in
the homatropine eyes (2.3 ± 1.7 vs 4.0 ± 2.1, P = 0.014 for VAS, 1.6 ± 1.0 vs 2.5 ± 1.0, P = 0.038 for VRS, and 6.8 ± 5.7 vs
12.0 ± 8.9, P = 0.005 for PRI). No delayed epithelial healing was observed.
Conclusion: Homatropine eye drops may be useful for reducing pain after Photorefractive keratectomy.
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Cornea is one of the most heavily innervated tissues in the
body. Nerve density of the cornea is estimated to be 300–
400 times higher than the human skin.1 Sensory nerve fibers
extend from the long ciliary branch of trigeminal nerve and
form a rich subepithelial nerve plexus. Loss of superficial epi-
thelium leads to exposure of these nerve endings and causes
severe pain and discomfort. This exposure will occur in many
conditions like corneal abrasion, corneal exposure and post
surgical conditions like photo-ablation.
Photorefractive keratectomy (PRK), performed with exci-
mer laser, has been a widely used operation in many coun-
tries.2 Since considerable parts of the anterior corneacontaining heavy innervations are removed in this procedure,
patients usually experience severe pain and discomfort.2 Pain
is especially severe in the first 24 h after surgery and will de-
crease after 3 days with further healing of the corneal epithe-
lium.2 This pain is usually managed with systemic analgesics.3
Many topical ocular drops have been used for post operative
pain of PRK patients. Topical nepafenac, diclofenac, tetra-
caine, ketorolac, diluted proparacaine and morphine are
among the drugs that are used for this purpose.4–10
Cycloplegics are medications that are usually used for
inducing mydriasis as well as pain relief in ophthalmology.
Considering their effect on aborting ciliary body spasm, they
are widely used to smooth the pain secondary to ocular sur-
face abrasions and uveitis.11,12 To the best of our knowledge,e:
al.com
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post PRK pain. In this contralateral eye study we evaluated
the effect of a topical cycloplegic drug, homatropine, on
relieving pain following PRK.Table 1. Pain score on visual analogue scale (VAS), verbal rating scale (VRS)
and pain rating index (PRI) at different time points after photorefractive
keratectomy.
Homatropine eye Control eye P value
VAS at 0.5 h 2.4 ± 2.1 3.4 ± 3.3 0.300
VAS at 24 h 2.5 ± 1.9 5.3 ± 2.5 0.004
VAS at 48 h 2.3 ± 1.7 4.0 ± 2.1 0.014
VRS at 0.5 h 1.6 ± 1.2 2.2 ± 1.5 0.144
VRS at 24 h 2.0 ± 1.2 3.2 ± 0.9 0.023
VRS at 48 h 1.6 ± 1.0 2.5 ± 1.0 0.038
PRI at 0.5 h 6.9 ± 5.6 7.9 ± 6.2 0.595
PRI at 24 h 9.4 ± 5.7 16.0 ± 9.0 0.031
PRI at 48 h 6.8 ± 5.7 12.0 ± 8.9 0.005Material and methods
In this double masked randomized clinical trial 15 patients
(30 eyes), who were candidates for bilateral PRK surgery be-
tween August and October 2008 were included. Institutional
review board and ethics committee approved the study. All
patients underwent initial complete ocular examinations
including manifest and cycloplegic refraction, slit lamp exam-
ination, intraocular pressure measurement, and dilated fun-
dus examinations. Patients with hyperopia and high myopia
(more than 6.00 diopters), previous ocular surgeries and
history of neurosensory pain disorders were excluded.
Epithelium was removed using a spatula after instilling
20% alcohol over the cornea for 20 s. Laser ablation was per-
formed using a Technolas 217 (Bausch & Lomb). Depth of
ablation was based on the preoperative refractive error.
After corneal ablation, surgical sponge soaked in mitomy-
cin C was placed over the cornea for 20 s and then cornea
surface washed with 100 ml of balanced salt solution. After
surgery a plano bandage contact lens was placed on the cor-
nea and the contact lenses were removed at the third post-
operative day. Postoperative medications were topical
betamethasone, four times daily, topical chloramphenicol,
four times daily and oral acetaminophen as needed by pa-
tient’s discretion. Topical homatropine (Sina Darou, Tehran,
Iran), four times daily, was added to the postoperative med-
ications for only one eye (homatropine eye). The patients
were instructed to use the homatropine drops for the same
eye and those who reported mistakes were excluded from
the study. All patients were evaluated daily for epithelial
wound healing and visual recovery. Randomization of the
eyes was performed by one of the authors (SS). The surgeon,
patients and psychiatrist evaluating patients’ pain were all
unaware of the randomization process and the eye which
was receiving homatropine drops.
All the procedures and medications were similar for both
eyes except for homatropine drops. Before surgery, patients
were oriented to pain questionnaire by the psychiatrist. Pain
rating scales were explained to the patients and reevaluated
to confirm understanding. Patients were asked about pain
and discomfort in each eye and requested to express his/
her pain experience with three different subjective pain scor-
ing questionnaires: visual analogue scale (VAS), verbal rating
scale (VRS) and Short-Form McGill Pain Questionnaire. For vi-
sual analogue scale, the patients were asked to indicate their
pain sensation severity in a linear line marked from 0 for ‘‘no
pain’’ to 10 for ‘‘the most severe intolerable pain I have ever
experienced.’’13 For recording verbal rating scale (VRS), pa-
tients were asked to rate their experience of pain on the
Keele verbal pain chart.14,15 This scale allowed them to score
pain in a semiquantitative way: 0 = no pain, 1 = minimal pain,
2 = moderate pain, 3 = severe pain, and 4 = agonizing pain.
Short-Form McGill Pain Questionnaire is a 15-item form of
the longer McGill Pain Questionnaire. The questionnaire
measures pain score as a sum of the sensory and affective
pain rating index (S-PRI and A-PRI). Each descriptor is rated
on a 4-point scale; none, mild, moderate or severe.16,17Data were entered using SPSS software (SPSS 15.0, SPSS
Inc., Chicago, IL). Paired t test was used for analysis and P va-
lue less than 0.05 was considered significant.
Results
Thirty patients entered in this study. Fifteen patients were
excluded due to using homatropine for both eyes or missed
follow up. Data from 15 patients, each comprised of one
homatropine treated and one control eye were analyzed.
Mean corrected refractive error was not different between
homatropine and control eyes (3.73 ± 2.1 and 3.75 ± 1.9
respectively, P = 0.89).
Table 1 shows the pain scores of the patients. VAS, VRS
and PRI scores, 0.5 h after operation, were not significantly
different between homatropine and control eyes (P = 0.3,
P = 0.l and P = 0.5, respectively). 24 and 48 h after surgery,
pain scores on VAS, VRS and PRI were all significantly lower
in homatropine eyes. Thirteen homatropine eyes (86.6%)
had a VAS score of less than 1 compared to control eyes both
at 24 and 48 h after operation. Ten homatropine eyes (66.6%)
had a VRS score of less than 1 compared to control eyes, 24
and 48 h after operation. This difference was observed in 12
homatropine eyes (80%) for PRI. Epithelium had been healed
on the third day after surgery in all eyes and contact lens was
removed simultaneously in both eyes.
Discussion
Photorefractive keratectomy is a safe and effective proce-
dure for mild to moderate refractive error correction.18,19 It is
the most widely used laser refractive surgery in the US military
service.20 Post operative pain is one of the most significant
disadvantages of PRK.21 Exposure of traumatized nerve end-
ings causes severe postoperative pain which usually lasts for
the first 3–4 days until corneal surface re-epithelialization oc-
curs. There is not a general agreement on the best approach
to manage postoperative pain in these patients.20 A variety
of systemic and topical medications have been used for pain
reduction after PRK. Oral non steroidal anti-inflammatory
drugs (NSAIDs), gabapentine, and opiates are among oral
medications that are being used so far with different success
and complication rates.20–22 Topical NSAID drugs are one of
the most popular medications to control post-PRK pain. Dic-
lofenac and ketorolac have been approved by FDA for pain
control with surface ablations. Bromfenac, a recently ap-
proved topical NSAID for the treatment of postoperative
inflammation and pain after cataract surgery, has also been
found to control pain following PRK.4 There are some
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relief and re-epithelialization time.23 Some papers reported
patients with corneal melting after topical NSAID medica-
tions especially with diclofenac drops.24,25
The cycloplegics, by relieving ciliary spasm, have a well
established effect on decreasing pain and discomfort in cor-
neal lesions.11,12,26 Our study showed that homatropine has
both statistical and clinical effects on pain reduction in PRK
patients. Some patients reported that they had a sense of
comfort in the eye treated with homatropine. Of the major
side effects of cycloplegics are photophobia due to pupillary
dilation and loss of accommodation. We routinely prescribe
UV-absorbing glasses for the first 3 days after the PRK and
there was little complaint about photophobia in our patients.
Although the study was not aimed at comparing epithelial
healing time between homatropine treated and non treated
eyes, the time of epithelial healing and bandage contact lens
removal was equal in both eyes. The small number of patients
is the main drawback of this study. Although patients were
masked, there may be the risk of bias secondary to the num-
ber of drops that they were using for each eye.
We used visual analogue score, verbal pain rating scale
and McGill pain rating index to evaluate subjective pain
experience. Although VAS and PRI have been used fre-
quently in studies for evaluating pain discomfort severity,
Keele‘s verbal rating scale for pain has been used scarcely
and this enhances the quality of measurements.14,15 In our
study the other eye of the patient was considered as control.
Evaluation of the pain severity in either eye might be influ-
enced by the pain experience in the other eye. So the pain
scores in this study might be different if homatropine and
control eyes were selected from different individuals.
In conclusion, this pilot study showed that homatropine is
effective for reducing post-PRK pain and discomfort. Cyclo-
plegics are cheap and safe medications without known dele-
terious effects on wound healing and could be helpful for
PRK patients in their early postoperative period. Other cyclo-
plegic drugs with different cycloplegic durations might be
effective and more convenient to use. Further studies with
a larger sample size are needed to establish the definitive ef-
fects of cycloplegics on post-PRK pain.
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